Matches in Wikidata for { <http://www.wikidata.org/entity/Q93274808> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q93274808 description "article scientifique publié en 2020" @default.
- Q93274808 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q93274808 description "im April 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q93274808 description "scientific article published on 27 April 2020" @default.
- Q93274808 description "wetenschappelijk artikel" @default.
- Q93274808 description "наукова стаття, опублікована 27 квітня 2020" @default.
- Q93274808 name "Public Health Outcomes May Differ After Switching from Brand-Name to Generic Angiotensin II Receptor Blockers" @default.
- Q93274808 name "Public Health Outcomes May Differ After Switching from Brand-Name to Generic Angiotensin II Receptor Blockers" @default.
- Q93274808 type Item @default.
- Q93274808 label "Public Health Outcomes May Differ After Switching from Brand-Name to Generic Angiotensin II Receptor Blockers" @default.
- Q93274808 label "Public Health Outcomes May Differ After Switching from Brand-Name to Generic Angiotensin II Receptor Blockers" @default.
- Q93274808 prefLabel "Public Health Outcomes May Differ After Switching from Brand-Name to Generic Angiotensin II Receptor Blockers" @default.
- Q93274808 prefLabel "Public Health Outcomes May Differ After Switching from Brand-Name to Generic Angiotensin II Receptor Blockers" @default.
- Q93274808 P1433 Q93274808-1F63EAE8-D536-405E-8BCB-86B61DC9DCB2 @default.
- Q93274808 P1476 Q93274808-73BEA890-5124-4E78-9256-D4A4DFED1CF0 @default.
- Q93274808 P2093 Q93274808-167DECD9-1917-4DF0-B29B-6518C9287A13 @default.
- Q93274808 P2093 Q93274808-23A4F755-08DD-401B-825B-C7D7AD949D9D @default.
- Q93274808 P2093 Q93274808-5F7864C7-C8C8-4AE0-8217-74B511F657C8 @default.
- Q93274808 P2093 Q93274808-A8FB9157-BF2B-47B5-9F4D-8DECB2BBEBE2 @default.
- Q93274808 P2093 Q93274808-B8C62770-9432-45A0-8E62-1065507462BD @default.
- Q93274808 P2093 Q93274808-CA8A04CF-F9D2-45F4-85D4-E82F5747552F @default.
- Q93274808 P2093 Q93274808-CF865F86-C6B2-4E92-B100-1A42AAE9D35D @default.
- Q93274808 P31 Q93274808-8464E874-D2C3-47EB-AE33-1A0E235C7257 @default.
- Q93274808 P356 Q93274808-491604FD-7D80-4478-A2A3-B119CEBBF11E @default.
- Q93274808 P577 Q93274808-2F1BA4A3-2546-4C66-8259-330973645145 @default.
- Q93274808 P698 Q93274808-8C14F0BC-845A-4655-B15E-D327681B11D6 @default.
- Q93274808 P356 S40268-020-00307-2 @default.
- Q93274808 P698 32342284 @default.
- Q93274808 P1433 Q26842117 @default.
- Q93274808 P1476 "Public Health Outcomes May Differ After Switching from Brand-Name to Generic Angiotensin II Receptor Blockers" @default.
- Q93274808 P2093 "Claudia Beaudoin" @default.
- Q93274808 P2093 "Claudia Blais" @default.
- Q93274808 P2093 "Denis Hamel" @default.
- Q93274808 P2093 "Jacinthe Leclerc" @default.
- Q93274808 P2093 "Line Guénette" @default.
- Q93274808 P2093 "Louis Rochette" @default.
- Q93274808 P2093 "Paul Poirier" @default.
- Q93274808 P31 Q13442814 @default.
- Q93274808 P356 "10.1007/S40268-020-00307-2" @default.
- Q93274808 P577 "2020-04-27T00:00:00Z" @default.
- Q93274808 P698 "32342284" @default.